---
$id: https://graph.org.ai/products/commodity/51294407
$type: Product
source: UNSPSC
code: "51294407"
title: "Metoxepin"
class: "51294400"
classTitle: "Antidepressant piperazines"
family: "51290000"
familyTitle: "Antidepressants"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Metoxepin

**UNSPSC Code**: 51294407
**Class**: [Antidepressant piperazines](Antidepressant piperazines.mdx)
**Family**: [Antidepressants](../Antidepressants.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antidepressant agent with the molecular formula C20H22N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Z8EZK2DSIT, chemically known as 1-(8-methoxydibenz(b,f)oxepin-10-yl)-4-methylpiperazine but generally known as metoxepin, which bears US NIH Compound Identifier 32226. European Medicines Agency schedules Metoxepin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08913MIG. The term METOXEPIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 29, No. 10 1975, List 15). METOXEPIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule metoxepin under HS 29349990 and SITC 51579. As of Q4 2014, METOXEPIN remains the US FDA Preferred Term for this commodity. Metoxepin bears US NLM identifiers UMLS ID C1881811 and NCI Concept Code C66135. SMILES: O1c2c(C(=Cc3c1cccc3)N1CCN(CC1)C)cc(OC)cc2.

